title: Extramedullary relapse in the so-called 'sanctuary' sites for chemotherapy after donor lymphocyte infusion.
authors.forename: S
authors.initials: S
authors.lastname: Seo
authors.forename: M
authors.initials: M
authors.lastname: Kami
authors.forename: H
authors.initials: H
authors.lastname: Honda
authors.forename: T
authors.initials: T
authors.lastname: Kashima
authors.forename: T
authors.initials: T
authors.lastname: Matsumura
authors.forename: A
authors.initials: A
authors.lastname: Moriya
authors.forename: U
authors.initials: U
authors.lastname: Machida
authors.forename: Y
authors.initials: Y
authors.lastname: Kanda
authors.forename: S
authors.initials: S
authors.lastname: Chiba
authors.forename: H
authors.initials: H
authors.lastname: Hirai
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002490:Central Nervous System / Q000473:pathology; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy / Q000473:pathology* / Q000628:therapy*; D017254:Leukemic Infiltration / Q000473:pathology / Q000628:therapy*; D017710:Lymphocyte Transfusion; D008297:Male; D012008:Recurrence; D013737:Testis / Q000473:pathology; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents